Mark Weinstein – Strategic Advisor – Investor
Mark brings a wealth of both industry knowledge and experience in developing technology companies. Mark served as CEO, President and Board of Directors member of BioClinica from 1997 to 2015. Over that 17 year period, Mark guided BioClinica from a $2 million dollar revenue 30 person single product company to a 1,200 person multi-product/multi-sector company with revenues of over $200 million dollars. Although diverse, all of BioClinicas’ activities were focused on helping pharmaceutical, bio-technology and medical device companies getting their products approved.
Prior to BioClinica, Mark’s experience included 6 years at Medical Economics Data where he had progressively increased responsibilities. Titles included Vice President of Operations, Vice President of US Subsidiaries and President of the International Group.
Mr. Weinstein received his Bachelor of Arts degree from University of Virginia and his Masters in Business Administration (MBA) from The College of William and Mary